
NovaBay Pharmaceuticals, Inc.
NBY
NBY: NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
moreShow NBY Financials
Recent trades of NBY by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NBY's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on NBY's company Twitter account
Number of mentions of NBY in WallStreetBets Daily Discussion
Recent insights relating to NBY
Recent picks made for NBY stock on CNBC
ETFs with the largest estimated holdings in NBY
Flights by private jets registered to NBY